Fosmanogepix Uses, Dosage, Side Effects and more

Fosmanogepix is under investigation in clinical trial NCT03604705 (An Efficacy and Safety Study of APX001 in Non-Neutropenic Patients With Candidemia).

Trade Name Fosmanogepix
Generic Fosmanogepix
Fosmanogepix Other Names Fosmanogepix
Type
Formula C22H21N4O6P
Weight Average: 468.406
Monoisotopic: 468.11987141
Groups Investigational
Therapeutic Class
Manufacturer
Available Country
Last Updated: January 7, 2025 at 1:49 am

Innovators Monograph

*** Taking medicines without doctor's advice can cause long-term problems.
Share